NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/08/2025
Back to search
Official data from USPTO
REPORTINGPHARM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
REPORTINGPHARM
ST13
US500000097884473Class
42
Filing
97884473
Registration
7756507
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
04/09/2025
Trademark type
Word
Nice classes
42
Filing date
04/12/2023
Registration date
04/08/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/08/2025
Last transaction
04/09/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
05/30/2024
First use in commerce
05/30/2024
Drawing code
4
Owner type
16
Owner location
Peoria, IL
Examiner
MCCARTHY, JOSEPH
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Health Strategy, LLC
Representatives
Annette P. Heller TM LAW & ASSOCIATES
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Providing temporary use of non-downloadable on-lineinternet-based software platform enabling users to analyze a variety of information concerning pharmaceuticals
Publications
History of USPTO decisions and trademark events.
27 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
04/08/2025
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/13/2025
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
03/13/2025
IUAA
USE AMENDMENT ACCEPTED
03/13/2025
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
12/27/2024
IUAF
USE AMENDMENT FILED
12/27/2024
EAAU
TEAS AMENDMENT OF USE RECEIVED
12/27/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
12/27/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/28/2024
GNFR
FINAL REFUSAL E-MAILED
10/28/2024
CNFR
FINAL REFUSAL WRITTEN
10/28/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/15/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/15/2024
ALIE
ASSIGNED TO LIE
10/11/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/27/2024
NREV
NOTICE OF REVIVAL - E-MAILED
06/27/2024
PETG
PETITION TO REVIVE-GRANTED
06/27/2024
PROA
TEAS PETITION TO REVIVE RECEIVED
06/27/2024
MAB2
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
05/01/2024
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
05/01/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/16/2024
GNRT
NON-FINAL ACTION E-MAILED
01/16/2024
CNRT
NON-FINAL ACTION WRITTEN
01/16/2024
DOCK
ASSIGNED TO EXAMINER
01/09/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/06/2023
NWAP
NEW APPLICATION ENTERED
04/15/2023
Continuous trademark protection
Get notified about every new filing that threatens REPORTINGPHARM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.